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Abstract 
Purpose 
To report the feasibility, accuracy and initial clinical experience of the use of real-time 
magnetic resonance navigated ultrasound (rtMRnUS) in the surgical planning of 
breast conserving surgery (BCS) via guide wire insertion. 
 
Materials and Methods 
Twenty-nine participants were recruited into this prospective ethics committee 
approved study. The first four cases were utilised as a training set. Participants 
underwent a supine contrast enhanced breast MR examination with the arm on the 
affected side abducted emulating the ultrasound position. Prior to MR examination 
external fiducials with corresponding ink marks were placed, on the skin of the 
affected breast. The location of the external fiducials and ink marks acted as co-
registration pairs. MR examinations included both functional and morphological 
images. 
A LOGIQ E9 ultrasound system (GE Healthcare, Milwaukee, WI, USA) equipped 
with a 6-15 MHz transducer was utilised for rtMRnUS. To facilitate point co-
registration of the previously acquired MR dataset with the real-time ultrasound, co-
registration pairs were identified on both imaging modalities. The following co-
registration quality metrics were recorded: root mean square deviation (RMSD), 
lesion and global accuracies. Post co-registration guide wire insertion was 
performed. 
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Results 
Co-registration was successfully undertaken in all participants. Results from 25 
participants are presented. The median (min, max) RMSD was 3.3mm (0.6mm, 
8.8mm). Global accuracy was assessed as very good (8), good (12), moderate (3) 
and poor (2) while median (min, max) lesion accuracy was recorded at 8.9mm 
(2.1mm, 33.2mm). Positive margin status was noted from 4 participants following 
rtMRnUS facilitated guide wire insertion. 
 
Conclusion 
The use of rtMRnUS to facilitate guide wire insertion is a feasible technique. 
Generally, very good or good global registration can be expected. Lesion accuracy 
results indicate a median difference, in 3D space, of 9mm can be expected between 
image modalities. 
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Introduction 
Localised breast tumours are typically managed by breast conserving surgery (BCS) 
combined with adjuvant radiotherapy, which provides comparable survival outcomes 
to traditional mastectomy [1,2], whilst providing a better cosmetic result. However, if 
histopathology of the resected specimen reveals tumour extending to the surgical 
margin, so called positive margin, then further resection is advised until a clear 
margin is obtained, since margin positivity is an important risk factor for recurrent 
disease [1]. Re-operation for positive tumour margin status can result in poor 
cosmetic outcome, increased patient anxiety, delayed adjuvant therapy and 
increased treatment costs [1,2]. The frequency of positive margins following BCS 
varies depending on the health care setting, however, in the UK the reoperation rate 
is around 20% [3].  
Ultrasound or stereotactic guided wire insertion is frequently used in the pre-surgical 
localisation of small breast cancers prior to BCS. However localisation of a lesion 
using a guide wire will be inaccurate if the full extent of the disease is not identified 
by the imaging modality used to guide the wire insertion. Given its ease of access 
and low cost ultrasound is frequently utilised to direct wire insertion, yet the accuracy 
of ultrasound in delineating breast malignancies is known to be inferior to MRI [4]. 
Conversely, while MR guided wire insertion might improve accuracy, it has limited 
availability, requires greater time and at increased cost. Recently, real-time MRI 
navigated ultrasound (rtMRnUS) has been introduced, that combines the benefits of 
both ultrasound and MRI. In this technique a previously acquired 3D MR dataset is 
co-registered to real-time US images. Both modalities are displayed simultaneously 
and the MR images can be used to navigate real-time US, allowing insertion of the 
guide wire into the optimum location. 
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Two papers by Rizzatto [5], Fausto [6] and co-workers explored the feasibility of co-
registering MR and US images via an rtMRnUS technique in healthy volunteers and 
patients. The authors concluded that rtMRnUS is both accurate and reproducible. A 
number of authors have previously reported a superior detection rate for rtMRnUS 
than second look or targeted ultrasound in the detection of enhancing lesions 
previously identified on MR [7-10]. Chang et al. reported that rtMRnUS provided a 
more accurate estimation of breast tumour longest dimension than ultrasound alone 
when compared to histopathology results [11]. 
The aim of this study was to evaluate the feasibility of utilising rtMRnUS in the 
surgical planning of BCS, via guide wire insertion, and to document initial clinical 
experience. Both lesion and global registration accuracy were assessed along with 
the number of failed rtMRnUS co-registrations.  
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Materials and Methods 
Participants 
Ethic committee approval was obtained for this prospective study. Potential 
participants were prospectively approached regarding study participation if following 
triple assessment (mammography, ultrasound and biopsy) they had a biopsy proven 
malignancy and were scheduled for BCS. Exclusion criteria included normal 
contraindications to MRI and/or gadolinium based contrast agents. Following written 
informed consent, study participants underwent a supine contrast enhanced breast 
MRI examination prior to rtMRnUS guide wire insertion and subsequent BCS. 
MR Imaging and Post Processing 
Prior to imaging four MR visible external fiducial markers (vitamin E capsules) were 
placed in the 12-, 3-, 6-, and 9-o’clock positions relative to the nipple. If the lesion 
was located at an extreme edge of the breast, such as in the axillary tail, then at 
least one additional fiducial was placed in that location. The locations of the external 
fiducials were marked on the skin with indelible ink. The participant was imaged in 
the supine position with the arm on the affected side abducted, thereby emulating 
the ultrasound position. A plastic bridge was utilised to support a 32 channel phased 
array torso receiver coil (NeoCoil LLC, Pewaukee, WI, USA) and ensure that it did 
not deform the affected breast, but allowed the breast to fall into a natural position.  
All MRI imaging was undertaken on a 3.0T MR750 Discovery scanner (GE 
Healthcare, Milwaukee, WI, USA) in conjunction with a dedicated 32-channel torso 
coil. Participants underwent a limited breast examination consisting of a 3 plane 
localiser; axial 3D T1W LAVA-flex dynamic test phase (same imaging parameters as 
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the dynamic series) to review anatomical coverage and ensure visualisation of 
external fiducials; axial 3D T1W LAVA-flex acquired dynamically over 19 phases with 
a 14 second temporal resolution (TR/TE 3.9/1.8ms, flip 12°, slice/gap 4/0mm, matrix 
288x160, FOV 38x30cm); and a delayed post contrast high spatial resolution axial 
3D T1W LAVA-flex (TR/TE 4.3/1.9ms, flip 12°, slice/gap 1.2/-0.6mm, matrix 
320x224, FOV 38x30cm). Total scan acquisition time for all four sequences was 
under 7 minutes. Gadolinium containing contrast agent was administered at the start 
of the 3rd phase of the dynamic examination, via a bolus injection (0.05 mmol/kg 
body weight) by a Spectris Solaris power injector (Medrad, Warrendale, PA, USA) 
and this was immediately followed by a 20ml saline flush; total injection time 10 
seconds for all patients. 
Post-acquisition MR images were reviewed on an Advantage Workstation (GE 
Healthcare, Milwaukee, USA) with post processing software (subtraction, multi-
planar reformatting, maximum intensity projections and dynamic curve assessment) 
to identify the malignant lesion. An additional image series was generated by 
subtracting a ‘water-only’ pre contrast phase from a ‘water-only’ post contrast 
dynamic phase, thereby displaying the greatest contrast uptake in the identified 
malignant lesion. 
LAVA-flex sequence results in four different T1W image types – in-phase, out-of-
phase, water-only and fat-only. The following series were transferred to the rtMRnUS 
system: in-phase dynamic test phase, water-only subtraction and water-only delayed 
post contrast high spatial resolution. The in-phase images provided good T1W 
anatomical detail while highlighting the location of the fiducials. These images were 
utilised to co-register the MR data to the real-time ultrasound. The water-only 
subtraction and delayed post contrast high spatial resolution images were 
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subsequently used to aid ultrasound operator navigation, based on lesion location 
and extent. 
Real-time MR Navigated Ultrasound 
A LOGIQ E9 ultrasound system equipped with a 6-15 MHz broad spectrum linear 
matrix array transducer (ML6-15) (GE Healthcare, Milwaukee, WI, USA) was 
employed for rtMRnUS. For the purposes of real-time volume navigation, the LOGIQ 
E9 is fitted with a fixed electromagnetic transmitter with a defined operating volume 
and two electromagnetic sensors mounted on the transducer. This arrangement 
provides a means of determining the transducer position and orientation relative to 
the transmitted magnetic field. 
All rtMRnUS examinations were undertaken by either a Consultant Breast 
Radiologist or a Consultant Breast Radiographer with a minimum of 5 years 
experience in breast ultrasound, assisted by researchers trained in the application of 
the LOGIQ E9 system for rtMRnUS purposes. Once again the participant was 
imaged in a supine position with the arm on the affected side abducted. Since the 
breast is an easily deformable organ, minimal transducer pressure was applied 
throughout the co-registration process.  
To facilitate point co-registration of the previously acquired MR dataset with the real-
time ultrasound, the centre of the transducer was placed over the central location of 
the external fiducial, as indicated by the skin ink mark.  This skin position was 
recorded on both the real-time ultrasound image and on the in-phase MR dataset. 
This procedure was repeated for at least three fiducial points. The choice of which 
three fiducials to use was based on the location of the tumour. For example, if the 
lesion was located in an upper central location then the fuducials located at 9-, 12-,  
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and 3-o’clock were used. However, if the lesion was located in a left upper outer 
location then the 12- and 3-o’clock fiducials were employed, together with the 
additional lesion related fiducial.   
Once three co-registration pairs were recorded the ultrasound system registered the 
MR and ultrasound and provided a quality measure (root mean square deviation, 
RMSD). If more than three co-registration points were identified the ultrasound 
system utilised the 3 co-registration point pairings that resulted in the lowest RMSD. 
Once the MR and ultrasound images were registered the LOGIQ E9 system 
simultaneously reformatted the 3D MR dataset to match the position and orientation 
of the ultrasound image and applied the resulting registration matrix to the two 
remaining MR datasets. Since the registration matrix had been applied to all the MR 
datasets it was possible to switch between MR image types, while performing the 
real-time ultrasound, without repeating the co-registration process.  
Following co-registration the RMSD was recorded. Additionally, both lesion and 
global co-registration accuracy was assessed. Lesion co-registration accuracy was 
determined by separately recording the centre of the lesion on both the real-time 
ultrasound image and on the MR dataset. Once the lesion centre had been recorded 
on both imaging modalities, the LOGIQ E9 system calculated the difference between 
the two points in 3D space thereby determining the accuracy. Global co-registration 
accuracy was determined qualitatively by the performing clinician using a five point 
scoring system (very poor – registration either does not match or only matches in a 
very limited area of the breast, poor – registration only matches over a limited portion 
of the breast, moderate – registration matches well but not globally over the whole 
breast, good – registration matches well globally over the whole breast, very good – 
registration matches almost exactly globally over the whole breast). 
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Once co-registration had been achieved the clinician was free to perform guide wire 
insertion either under rtMRnUS or purely under ultrasound guidance albeit with the 
cognitively retained MR information.  
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Results 
Twenty-nine participants were recruited between November 2012 and March 2014.  
To facilitate familiarisation with the co-registration process the first four cases were 
utilised as a training set. Consequently, the results of twenty-five participants with a 
median (min, max) age of 61 (48-72) years are presented. Twenty-eight lesions were 
identified with a median (min, max) histopathological diameter of 11mm (5mm, 
19mm). Further participant and lesion characteristics are presented in Table 1. 
Following standard triple assessment all study participants were believed to have a 
solitary malignancy. Supine breast MR concurred with the results of triple 
assessment in all but two cases; an additional focus of disease was identified in one 
case and a further two foci of malignancy discovered in the remaining case. 
The median (min, max) interval between MRI and rtMRnUS was 1 day (1 day, 5 
days). Co-registration was successfully undertaken in all participants. The median 
(min, max) RMSD was 3.3mm (0.6mm, 8.8mm). Global accuracy was assessed as 
very good (8), good (12), moderate (3), poor (2) and very poor (0).  
At least one enhancing MR lesion was identified in all participants, however, in one 
case this appears to have represented a false positive MR finding. MR demonstrated 
a lesion in the lateral aspect of the breast.  However at rtMRnUS no lesion was 
visible on the ultrasound in the area highlighted by the supine MR examination. 
Review of the findings at triple assessment indicated a medial lesion. Ultrasound 
investigation of the medial aspect of the breast identified a lesion which was 
subsequently proven malignant. Routine ultrasound as part of standard triple 
assessment identified 25 lesions in 25 participants whereas rtMRnUS revealed 27 
lesions in 24 subjects. Consequently, lesion accuracy is reported for 24 participants 
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since for this metric the lesion must be visible on both modalities. Median (min, max) 
lesion accuracy was recorded at 8.9mm (2.1mm, 33.2mm) from 25 lesions (lesion 
accuracy is not presented for 27 lesions since in the case with three MR enhancing 
areas, lesion accuracy was only recorded for the index lesion).  
Representative rtMRnUS images are presented in Fig. 1 and 2.  
Following rtMRnUS facilitated guide wire insertion and subsequent BCS, 
histopathology revealed positive margins in 4/25 (16%) participants, two with DCIS 
alone and two with both invasive and in-situ disease identified at the margin. 
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Discussion 
This study investigated the feasibility of using supine MR images for rtMRnUS 
mediated guide wire insertion, to facilitate surgical planning of BCS. Additionally, 
metrics of co-registration quality such as RMSD, lesion and global registration 
accuracy were assessed. Finally, initial clinical experience is discussed. 
For this study co-registration accuracy as determined by RMSD resulted in a median 
(min. max.) error of 3.3mm (0.6mm, 8.8mm). Rizzatto [5], Fausto [6] and co-workers 
reported co-registration accuracy from five healthy volunteers utilizing the same 
ultrasound system and co-registration methodology as this study. Based on five 
point-to-probe measurements (three external fiducials, the nipple and an internal 
mammary artery) a ‘misalignment of about 0.5cm’ [6] was reported. Rizzatto et al. [5] 
further reported that preliminary clinical experience in 41 patients resulted in good 
co-registration in ‘almost all’ cases.  
Two reports by Nakano et al. [7, 8] reported the co-registration accuracy with 
reference to a lesion. The experimental set-up by Nakano and co-workers employed 
both an electromagnetic field and a transducer mounted electromagnetic sensor 
similar to this work. However, to allow co-registration of the two image modalities 
only the nipple was utilised as a co-registration reference point. In the first paper, 
Nakano et al. [7] reported a 7mm difference between the US and MR image with 
reference to the index lesion. The later study [8] reported a mean 3D positioning 
error of 12.0mm (SD±7.5mm; range 2 to 40mm) between the US and MR lesion 
location from 63 tumours. The level of lesion co-registration accuracy was similar in 
our study to the reports by Nakano et al. [7, 8] with a median (min, max) lesion 
accuracy of 8.9mm (2.1mm, 33.2mm) from 25 lesions. 
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When considering the accuracy of co-registration for an organ such as the breast, it 
is important to realise that any quality metric assigned to that registration may not be 
appropriate to the whole breast. If one considers a hemisphere as a simplified 
representation of a breast, the pole of the hemisphere would represent the nipple 
and external fiducials would be placed in 12-, 3-, 6-, and 9-o’clock positions relative 
to the nipple. Even if the RMSD following co-registration is very low, it only 
represents the geometry relative to the co-registration pairs utilised in the registration 
process. Consequently, the registration quality distant to these co-registration pairs 
may be significantly poorer than the RMSD indicates. It is for this reason that in our 
methodology if the index lesion was known to be located at an extreme edge of the 
breast, such as the axillary tail, then at least one additional fiducial was placed in that 
location, in the hope that the registration geometry would encompass the area of the 
breast containing the index lesion. The study by Nakano et al. [8], in which the nipple 
represented the registration reference point, investigated this problem by comparing 
the lesion accuracy from proximal tumours (<40mm distance to nipple) against distal 
lesions (≥40mm distance to nipple). A greater but non-significant difference was 
noted in lesion positional error for distal (13.7mm SD±8.6mm; range 5 to 39mm) 
compared to proximal (11.0mm SD±6.8mm; range 2 to 40mm) tumours.  
In the current study “global” co-registration accuracy was assessed qualitatively by 
the performing clinician on a five point scoring system. Co-registration accuracy was 
assessed by comparing the location of prominent features such as nipple, 
parenchyma, internal mammary nodes and vasculature on both imaging modalities. 
In three cases global accuracy was assessed as moderate and poor in a further two 
cases. However, the median (min, max) RMSD in these five cases was 4.1mm 
(2.9mm, 5.3mm), which was similar to the whole cohort at 3.3mm (0.6mm, 8.8mm). 
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Consequently, it seems that while a co-registration quality metric is useful, the 
operator must consider its validity in relation to the lesion position relative to the co-
registration pairs utilised in the registration process.  
Our initial clinical experience indicates that transducer pressure and breast size are 
the main factors that impact on rtMRnUS co-registration accuracy. Transducer 
pressure will obviously affect not only the co-registration accuracy, but also image 
quality. During the co-registration process as little transducer pressure as possible is 
used to ensure the breast maintains a shape similar to that obtained at MR imaging. 
Following registration if transducer pressure is increased the breast deforms and the 
registration matrix is invalidated. Consequently, areas highlighted on the two image 
modalities will not represent the same tissue. The disadvantage of reduced 
transducer pressure is poorer ultrasound image quality consequent to inferior 
acoustic coupling. In our clinical experience a combination of light and standard 
transducer pressures might be required to identify lesions. Initially, light transducer 
pressure is applied for co-registration purposes. Following registration MR images 
are used to navigate the ultrasound operator to the location of the MR enhancing 
lesion via the real-time ultrasound. However, we have observed that occasionally the 
lesion is not visible on the ultrasound images. If the transducer pressure is 
increased, the registration matrix will become invalid but the image quality will 
improve, and the ultrasound operator can interrogate tissue in that area of the 
breast. Frequently, this will reveal the abnormality. If the transducer pressure is 
reduced and the breast returns to its normal shape the initial registration matrix will 
be valid once more. 
Unlike Fausto et al. [6] we did not exclude participants based on breast size and 
although not assessed formally we did note that larger breasts can be more difficult 
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to co-register. Nevertheless, we were able to perform rtMRnUS in all cases. 
Primarily, we believe that larger breasts can pose a co-registration challenge due to 
the greater range of deformation, both in terms of the position the breast naturally 
falls into when the patient is supine and in response to transducer pressure. By 
comparison smaller breasts have a smaller range of deformation. 
The use of rtMRnUS seems to result in a number of benefits. Chang et al. [11] 
reported that rtMRnUS provided a more accurate estimation of breast tumour longest 
dimension than ultrasound alone, when compared to histopathology results. 
Additionally, increased detection rates have been reported for rtMRnUS compared to 
second look ultrasound, for the detection of previously highlighted MR enhancing 
lesions [7-10]. These attributes would seem to make rtMRnUS an ideal tool to 
ensure guide wire insertion is optimal. However, when undertaking procedures such 
as biopsy and guide wire insertion under real-time ultrasound control the technique 
used can impede direct rtMRnUS control. During biopsy and guide wire insertion the 
breast is compressed by the transducer and the operator’s hand to ensure 
immobilisation of the lesion during the procedure [12]. This immobilisation results in 
a loss of registration due to deformation, as outlined above. However in our clinical 
experience rtMRnUS can navigate the ultrasound operator to the target lesion. Once 
the operator is ready to insert the guide wire, the transducer pressure is increased to 
immobilise the lesion, while visually tracking the real-time ultrasound location of the 
identified lesion. The operator then inserts the guide wire with cognitive reference to 
the MR extent of the lesion. 
Arguably, an alternative approach to rtMRnUS would be to insert guide wires solely 
under MR guidance. However, this not only necessitates dedicated localisation 
hardware and software, but also much greater access to MR scanner time. Further 
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not all lesion locations, such as chest wall, are accessible to MR guided techniques 
[13].  The technique outlined in this work minimises the necessary MR scan time 
while maximising the diagnostic accuracy. Additionally, guide wires can be inserted 
in the customary manner, albeit with rtMRnUS co-registration, by the regular staff. 
A number of limitations should be considered in relation to this report. Firstly, to 
facilitate co-registration MR data was acquired in the supine position to match the 
ultrasound position. The image quality of torso phased array supine breast MR is 
inferior to that obtained in the prone position with a breast coil. Nevertheless, all but 
one lesion demonstrated by triple assessment was identified by supine MR and three 
additional foci were also identified using this technique.  Secondly, the small number 
of participants and single centre nature of this study means that the results might be 
the subject of bias. Thirdly, due to the study design researchers were aware that 
participants were scheduled for BCS and therefore must have at least one lesion 
present, this knowledge might also have introduced bias into the results. 
In conclusion this study has demonstrated the accuracy of rtMRnUS following co-
registration of breast MR and ultrasound data. Furthermore, we have reported initial 
clinical experience in the use of rtMRnUS in the surgical planning of BCS via guide 
wire insertion and demonstrated that it is a feasible technique.  
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Table 1 
  Parameter  Participants 
Histological grade  n=28  
Grade I  12 
Grade II  9 
Grade III  7 
Histological type n=28  
NST  22 
Ductal  3 
Micropapillary  1 
Tubular  1 
Mixed lobular / NST  1 
Oestrogen receptor n=28  
Negative  3 
Positive  25 
Progesterone receptor n=28  
Negative  6 
Positive  22 
HER2 receptor n=28  
Negative  25 
Positive  3 
DCIS component n=25  
Low grade  10 
Intermediate grade  6 
High grade  3 
Not detected  6 
Axillary Node Status n=25  
Positive  3 
Negative  22 
Surgical Margin Status n=25  
Positive  4 
Negative  21 
Affected Breast n=25  
Left  13 
Right  12 
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Figure Legends 
Figure 1 
52yrs patient with palpable lesion, screening mammography: 9mm indeterminate 
mass upper central right breast, ultrasound: 10mm mass, biopsy: NST, Grade I, with 
associated high grade DCIS 
Top row left to right: Volume render demonstrating position of external fiducials, 
source image from dynamic sequence and positive enhancement integral map 
demonstrating an enhancing lesion superiorly within the right breast (arrow).  
Bottom row left to right: Co-registered rtMRnUS images demonstrating both global 
(nipple) and lesion registration. Green box on MR subtracted image represents US 
field of view. Green numbers and crosses represent central location of lesion from 
each modality and are used to calculated lesion accuracy. Co-registration via 
rtMRnUS resulted in a RMSD of 5.7mm, very good global registration and a lesion 
accuracy of 2.7mm. 
Figure 2 
61yrs patient with non-palpable mass, screening mammography: single 
indeterminate density upper inner quadrant right breast, ultrasound: single lesion, 
biopsy: Ductal, Grade II, DCIS present 
Panel a: Positive enhancement integral map demonstrating an enhancing lesion 
superiorly within the right breast and delayed post contrast high spatial resolution 
image (long arrow).  
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Panel b: Positive enhancement integral map demonstrating a second enhancing 
lesion superiorly within the right breast and delayed post contrast high spatial 
resolution image (short arrow).  
Panel c and d: Co-registered rtMRnUS ultrasound and subtracted dynamic MR 
images. Green box on MR image represents US field of view. Green numbers and 
crosses represent central location of lesion from each modality and are used to 
calculated lesion accuracy. Co-registered rtMRnUS resulted in a RMSD of 8.8mm, 
very good global registration and lesion accuracies of 7.9mm and 5.6mm. 
Panel e: Ultrasound image taken after rtMRnUS co-registration clearly demonstrated 
two separate lesions. Histopathology of surgical specimen confirmed presence of 
two separate malignant lesions: 1 upper inner, 1 upper central, both ductal NST, 
Grade II with associated high grade DCIS 
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